PH21951A - Octahydrothiazolo(4,5-g)quinolines and use as prolactin secretion inhibitors - Google Patents
Octahydrothiazolo(4,5-g)quinolines and use as prolactin secretion inhibitorsInfo
- Publication number
- PH21951A PH21951A PH32196A PH32196DA PH21951A PH 21951 A PH21951 A PH 21951A PH 32196 A PH32196 A PH 32196A PH 32196D A PH32196D A PH 32196DA PH 21951 A PH21951 A PH 21951A
- Authority
- PH
- Philippines
- Prior art keywords
- sub
- octahydrothiazolo
- quinolines
- alkyl
- secretion inhibitors
- Prior art date
Links
- 102000003946 Prolactin Human genes 0.000 title 1
- 108010057464 Prolactin Proteins 0.000 title 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 229940097325 prolactin Drugs 0.000 title 1
- 150000003248 quinolines Chemical class 0.000 title 1
- 230000028327 secretion Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 150000003839 salts Chemical group 0.000 abstract 2
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 125000005037 alkyl phenyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 229940052760 dopamine agonists Drugs 0.000 abstract 1
- 239000003136 dopamine receptor stimulating agent Substances 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- -1 substituted-octahydrothiazolo [4,5-g]quinolines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/30—Metal salts; Chelates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/604,687 US4537893A (en) | 1984-04-27 | 1984-04-27 | Octahydrothiazolo[4,5-g]quinolines and use as prolactin secretion inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH21951A true PH21951A (en) | 1988-04-15 |
Family
ID=24420601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH32196A PH21951A (en) | 1984-04-27 | 1985-04-25 | Octahydrothiazolo(4,5-g)quinolines and use as prolactin secretion inhibitors |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4537893A (fr) |
| EP (1) | EP0160502B1 (fr) |
| JP (1) | JPH0631262B2 (fr) |
| KR (1) | KR870001072B1 (fr) |
| CN (1) | CN85101547A (fr) |
| AT (1) | ATE67767T1 (fr) |
| AU (1) | AU564946B2 (fr) |
| CA (1) | CA1287356C (fr) |
| DE (1) | DE3584183D1 (fr) |
| DK (1) | DK185485A (fr) |
| ES (1) | ES8704177A1 (fr) |
| GR (1) | GR850989B (fr) |
| HU (1) | HU193113B (fr) |
| IL (1) | IL74988A0 (fr) |
| NZ (1) | NZ211863A (fr) |
| PH (1) | PH21951A (fr) |
| PT (1) | PT80339B (fr) |
| SU (1) | SU1414318A3 (fr) |
| ZA (1) | ZA852999B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4778894A (en) * | 1983-09-26 | 1988-10-18 | Eli Lilly And Company | 6 oxo-decahydroquinolines |
| US4977160A (en) * | 1986-06-16 | 1990-12-11 | Eli Lilly And Company | BCD tricyclic ergoline part-structure analogues |
| US5134143A (en) * | 1986-06-16 | 1992-07-28 | Eli Lilly And Company | BCD tricyclic ergoline part-structure analogues |
| US4826986A (en) * | 1986-06-16 | 1989-05-02 | Eli Lilly And Company | 6-Oxo-trans-octa- and decahydroquinolines |
| DE3624607A1 (de) * | 1986-07-21 | 1988-01-28 | Boehringer Ingelheim Kg | Neue tetrahydrobenzothiazolo-chinoline ihre herstellung und verwendung |
| US4762843A (en) * | 1986-09-15 | 1988-08-09 | Warner-Lambert Company | Hetero [f] fused carbocyclic pyridines as dopaminergic agents |
| US4939259A (en) * | 1989-07-24 | 1990-07-03 | Eli Lilly And Company | 2-oxo-pyrido[2,3-g]quinoline derivatives |
| US5006525A (en) * | 1989-07-24 | 1991-04-09 | Eli Lilly And Company | Dopamine agonists method |
| US4977149A (en) * | 1989-07-24 | 1990-12-11 | Eli Lilly And Company | Pyridoquinoline dopamine agonists, compositions and use |
| US5057515A (en) * | 1989-07-24 | 1991-10-15 | Eli Lilly And Company | Method for agonizing a dopamine receptor |
| US5416090A (en) * | 1991-01-31 | 1995-05-16 | Eli Lilly And Company | Method of treating inflammation |
| CA2144669A1 (fr) * | 1994-03-29 | 1995-09-30 | Kozo Akasaka | Derives du biphenyle |
| EP0816406B1 (fr) * | 1996-06-26 | 2000-09-06 | Bayer Ag | Procedure pour la préparation de produits de condensation pauvres en sel |
| WO2009139855A2 (fr) * | 2008-05-14 | 2009-11-19 | Ipsen Pharma S.A.S. | Compositions pharmaceutiques de conjugués somatostatine-dopamine |
| TWI537274B (zh) * | 2011-03-14 | 2016-06-11 | 橘生藥品工業股份有限公司 | 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2056224A1 (de) * | 1969-11-17 | 1971-06-03 | Danchi Seiyaku Co , Ltd , Tokio | Neue Thiazolochinohnderivate und Ver fahren zu ihrer Herstellung |
| US4198415A (en) * | 1979-01-22 | 1980-04-15 | Eli Lilly And Company | Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines |
| US4258049A (en) * | 1979-07-02 | 1981-03-24 | Smithkline Corporation | Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines |
| US4367231A (en) * | 1979-09-14 | 1983-01-04 | Eli Lilly And Company | Method of using octahydro pyrazolo[3,4-g]quinolines |
-
1984
- 1984-04-27 US US06/604,687 patent/US4537893A/en not_active Expired - Fee Related
-
1985
- 1985-04-01 CN CN198585101547A patent/CN85101547A/zh active Pending
- 1985-04-22 CA CA000479702A patent/CA1287356C/fr not_active Expired - Lifetime
- 1985-04-22 NZ NZ211863A patent/NZ211863A/en unknown
- 1985-04-22 ZA ZA852999A patent/ZA852999B/xx unknown
- 1985-04-22 SU SU853883101A patent/SU1414318A3/ru active
- 1985-04-23 IL IL74988A patent/IL74988A0/xx unknown
- 1985-04-23 GR GR850989A patent/GR850989B/el unknown
- 1985-04-23 PT PT80339A patent/PT80339B/pt not_active IP Right Cessation
- 1985-04-24 EP EP85302852A patent/EP0160502B1/fr not_active Expired - Lifetime
- 1985-04-24 AU AU41666/85A patent/AU564946B2/en not_active Ceased
- 1985-04-24 DE DE8585302852T patent/DE3584183D1/de not_active Expired - Lifetime
- 1985-04-24 AT AT85302852T patent/ATE67767T1/de not_active IP Right Cessation
- 1985-04-25 PH PH32196A patent/PH21951A/en unknown
- 1985-04-25 KR KR1019850002803A patent/KR870001072B1/ko not_active Expired
- 1985-04-25 ES ES542565A patent/ES8704177A1/es not_active Expired
- 1985-04-25 DK DK185485A patent/DK185485A/da not_active Application Discontinuation
- 1985-04-26 HU HU851624A patent/HU193113B/hu unknown
- 1985-04-26 JP JP60092157A patent/JPH0631262B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0160502A2 (fr) | 1985-11-06 |
| HU193113B (en) | 1987-08-28 |
| DK185485D0 (da) | 1985-04-25 |
| CA1287356C (fr) | 1991-08-06 |
| JPH0631262B2 (ja) | 1994-04-27 |
| PT80339A (en) | 1985-05-01 |
| EP0160502B1 (fr) | 1991-09-25 |
| ZA852999B (en) | 1986-11-26 |
| AU4166685A (en) | 1985-10-31 |
| CN85101547A (zh) | 1987-01-24 |
| JPS60233091A (ja) | 1985-11-19 |
| ES542565A0 (es) | 1987-03-16 |
| NZ211863A (en) | 1987-10-30 |
| IL74988A0 (en) | 1985-08-30 |
| HUT37624A (en) | 1986-01-23 |
| GR850989B (fr) | 1985-11-25 |
| SU1414318A3 (ru) | 1988-07-30 |
| ES8704177A1 (es) | 1987-03-16 |
| PT80339B (en) | 1987-02-16 |
| DK185485A (da) | 1985-10-28 |
| AU564946B2 (en) | 1987-09-03 |
| EP0160502A3 (en) | 1987-03-11 |
| DE3584183D1 (de) | 1991-10-31 |
| KR870001072B1 (ko) | 1987-05-27 |
| KR850007261A (ko) | 1985-12-02 |
| ATE67767T1 (de) | 1991-10-15 |
| US4537893A (en) | 1985-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH21951A (en) | Octahydrothiazolo(4,5-g)quinolines and use as prolactin secretion inhibitors | |
| GB1423006A (en) | Herbicidal compositions containing 4-phenoxy-phenoxy-propionic acid derivatives | |
| KR850001171A (ko) | 퀴놀린 화합물의 제조방법 | |
| ES8601201A1 (es) | Procedimiento para preparar derivados de imidazolina | |
| ES8704491A1 (es) | Procedimiento para la obtencion de nuevas piridopirimidinas | |
| AU7004687A (en) | 3-benzazepine derivatives | |
| DK67384D0 (da) | N-iminopyridiniumbetainderivater | |
| DE3461375D1 (en) | 1-acetonyl-2-(phenylimino)-imidazolidines, their addition salts, their pharmaceutical compositions and their preparation | |
| ES8800231A1 (es) | Un procedimiento para la preparacion de una trans-octahidro-oxazolo 4,5-g quinolina | |
| AU562643B2 (en) | N-arylpiperazine derivatives | |
| AU6599186A (en) | N-(6-(4-0-hydrxyphenyl-1,3-dioxan-cis-5-yl)hexenoyl) suphonamide derivatives | |
| EP0216323A3 (fr) | Dérivés de l'acide quinolonecarboxylique et leur préparation | |
| ES8605145A1 (es) | Perfeccionamientos en las maquinas pasteurizadoras para tra-tar termicamente mezclas liquidas destinadas a la fabrica- cion de helados | |
| EP0094774A3 (fr) | Dérivés de carboline | |
| ATE30675T1 (de) | Benzobicyclononanamin-derivate mit antikonvulsiven eigenschaften. |